🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The study of whether an infusion of blood cells called lymphocytes from a d...
Status
Terminated
Location
Rhode Island Hospital
Start Date
2013-03
Trial ID
NCT01685606
Treatments Being Tested
This phase II trial tests the effectiveness of golcadomide and rituximab as...
Status
Recruiting
Location
Mayo Clinic in Arizona
Start Date
2025-04-02
Trial ID
NCT06834373
The purpose of this study is to evaluate the safety and effectiveness of CA...
Status
Withdrawn
Location
Central laboratory in Fuda cancer hospital
Start Date
2015-09
Trial ID
NCT02575261
Treatments Being Tested
Patients with advanced stage melanoma who underwent vaccination with the Me...
Status
Suspended
Location
Multidisciplinary Oncology Center, University of Lausanne Hospitals
Start Date
2004-07
Trial ID
NCT00160992
Treatments Being Tested
This phase I trial evaluates the best dose, possible benefits and/or side e...
Status
Recruiting
Location
University of California Davis Comprehensive Cancer Center
Start Date
2021-09-17
Trial ID
NCT05052528
Treatments Being Tested
RATIONALE: Cytotoxic T lymphocytes (CTL) are cells of the immune system tha...
Status
Completed
Location
Dana-Farber Cancer Institute
Start Date
2007-08
Trial ID
NCT00512889
The study purpose is to learn about the safety and tolerability of IMA101 a...
Status
Completed
Location
University of Texas MD Anderson Cancer Center
Start Date
2017-06-30
Trial ID
NCT02876510
To evaluate the safety and efficacy of BIC-19GG, BIC-2019, BIC-2219 in the ...
Status
Recruiting
Location
Department of Pediatrics, Institute of Hematology and Blood Disease Hospital, Chinese Academy of Medical Sciences
Start Date
2024-02-01
Trial ID
NCT06355739
Treatments Being Tested
This phase I/II trial studies the side effects of laboratory-treated T cell...
Status
Terminated
Location
Fred Hutch/University of Washington Cancer Consortium
Start Date
2012-12-06
Trial ID
NCT01640301
A Phase I/II study of autologous T cells engineered using the Sleeping Beau...
Status
Terminated
Location
MD Anderson Cancer Center
Start Date
2022-04-04
Trial ID
NCT05194735
Treatments Being Tested